Zentalis Pharmaceuticals Statistics
Total Valuation
ZNTL has a market cap or net worth of $117.28 million. The enterprise value is -$173.01 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, before market open.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ZNTL has 71.95 million shares outstanding. The number of shares has increased by 4.33% in one year.
| Current Share Class | 71.95M |
| Shares Outstanding | 71.95M |
| Shares Change (YoY) | +4.33% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 1.40% |
| Owned by Institutions (%) | 62.44% |
| Float | 49.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.32 |
| Forward PS | n/a |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.94, with a Debt / Equity ratio of 0.14.
| Current Ratio | 6.94 |
| Quick Ratio | 6.73 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.84 |
Financial Efficiency
Return on equity (ROE) is -59.45% and return on invested capital (ROIC) is -29.78%.
| Return on Equity (ROE) | -59.45% |
| Return on Assets (ROA) | -26.62% |
| Return on Invested Capital (ROIC) | -29.78% |
| Return on Capital Employed (ROCE) | -59.93% |
| Revenue Per Employee | $161,837 |
| Profits Per Employee | -$1.35M |
| Employee Count | 166 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ZNTL has paid $34,000 in taxes.
| Income Tax | 34,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.65% in the last 52 weeks. The beta is 1.61, so ZNTL's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -84.65% |
| 50-Day Moving Average | 1.32 |
| 200-Day Moving Average | 2.49 |
| Relative Strength Index (RSI) | 68.11 |
| Average Volume (20 Days) | 859,038 |
Short Selling Information
The latest short interest is 6.17 million, so 8.58% of the outstanding shares have been sold short.
| Short Interest | 6.17M |
| Short Previous Month | 5.82M |
| Short % of Shares Out | 8.58% |
| Short % of Float | 12.36% |
| Short Ratio (days to cover) | 8.22 |
Income Statement
In the last 12 months, ZNTL had revenue of $26.87 million and -$224.19 million in losses. Loss per share was -$3.15.
| Revenue | 26.87M |
| Gross Profit | 26.87M |
| Operating Income | -200.52M |
| Pretax Income | -194.35M |
| Net Income | -224.19M |
| EBITDA | -199.29M |
| EBIT | -200.52M |
| Loss Per Share | -$3.15 |
Full Income StatementBalance Sheet
The company has $332.45 million in cash and $42.16 million in debt, giving a net cash position of $290.29 million or $4.03 per share.
| Cash & Cash Equivalents | 332.45M |
| Total Debt | 42.16M |
| Net Cash | 290.29M |
| Net Cash Per Share | $4.03 |
| Equity (Book Value) | 295.38M |
| Book Value Per Share | 4.11 |
| Working Capital | 293.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$151.52 million and capital expenditures -$181,000, giving a free cash flow of -$151.70 million.
| Operating Cash Flow | -151.52M |
| Capital Expenditures | -181,000 |
| Free Cash Flow | -151.70M |
| FCF Per Share | -$2.11 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -746.40% |
| Pretax Margin | -834.36% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ZNTL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.33% |
| Shareholder Yield | -4.33% |
| Earnings Yield | -191.15% |
| FCF Yield | -129.35% |
Dividend DetailsAnalyst Forecast
The average price target for ZNTL is $8.69, which is 433.13% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.69 |
| Price Target Difference | 433.13% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 21.64% |
| EPS Growth Forecast (5Y) | -31.40% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ZNTL has an Altman Z-Score of -2.31 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.31 |
| Piotroski F-Score | 1 |